UBS ASSET MANAGEMENT AMERICAS INC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 155 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$686,794
-6.8%
30,7290.0%0.00%
Q2 2023$737,1900.0%30,7290.0%0.00%
Q1 2023$737,190
-13.3%
30,729
-16.2%
0.00%
Q4 2022$850,418
-99.8%
36,656
+23.4%
0.00%
Q3 2022$476,067,000
-4.6%
29,717
+5.5%
0.00%
Q2 2022$498,978,000
-14.7%
28,159
-1.9%
0.00%
Q1 2022$584,637,000
+9.0%
28,7150.0%0.00%
Q4 2021$536,396,000
-5.4%
28,7150.0%0.00%
Q3 2021$566,833,000
-16.5%
28,7150.0%0.00%
Q2 2021$678,823,000
+0.8%
28,715
+1.0%
0.00%
Q1 2021$673,648,000
+10.5%
28,424
-6.6%
0.00%
Q4 2020$609,594,000
+6.0%
30,434
+10.2%
0.00%
Q3 2020$574,883,000
+17.0%
27,612
-1.6%
0.00%
Q2 2020$491,261,000
-88.1%
28,072
-88.9%
0.00%
-100.0%
Q1 2020$4,126,428,000
-31.3%
252,690
-13.4%
0.00%
-25.0%
Q4 2019$6,005,841,000
+78.4%
291,829
-0.5%
0.00%
+100.0%
Q3 2019$3,366,970,000
-14.0%
293,290
-1.5%
0.00%
-33.3%
Q2 2019$3,914,912,000
-14.8%
297,712
-2.0%
0.00%0.0%
Q1 2019$4,597,231,000
-12.3%
303,648
-0.5%
0.00%
-40.0%
Q4 2018$5,241,675,000
+2744.9%
305,281
+2342.2%
0.01%
Q3 2018$184,250,000
-38.2%
12,5000.0%0.00%
Q2 2018$298,125,00012,5000.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders